Nicola Fracchiolla - Concepedia

Author

Nicola Fracchiolla

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico ORCID

Also Known As

Fracchiolla, Nicola Stefano, Lior Nesher, N Fracchiolla, N S Fracchiolla, N. Fracchiolla, N. S. Fracchiolla, N.S. Fracchiolla, NS Fracchiolla, Nicola S. Fracchiolla, Nicola Fracchiolla

179

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Istituti di Ricovero e Cura a Carattere Scientifico University of Milan Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia University of Rome Tor Vergata

About

Nicola Fracchiolla is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	657
2	Health Sciences	9	9	343
3	Public Health	3	3	165
4	Natural Sciences	2	2	37
5	Allergy	1	1	12

Nicola Fracchiolla

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci Laura Pasqualucci, Anna Migliazza, Nicola Fracchiolla, Proceedings of the National Academy of Sciences	1998	538
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults Robin Foà, Renato Bassan, Antonella Vitale, New England Journal of Medicine	2020	467
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Journal of Hematology & Oncology	2021	312
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Blood	2019	208
Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis Nicoletta Del Papa, Gualtiero I. Colombo, Nicola Fracchiolla, Arthritis & Rheumatism	2004	169
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine Keith W. Pratz, Brian A. Jonas, Vinod Pullarkat, Journal of Clinical Oncology	2021	156
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL Robin Foà, Renato Bassan, Loredana Elia, Journal of Clinical Oncology	2023	122
Central Venous Catheter-related Complications in Patients with Hematological Malignancies: A Retrospective Analysis of Risk Factors and Prophylactic Measures A. Cortelezzi, Nicola Fracchiolla, Patrick Maisonneuve, Leukemia & lymphoma/Leukemia and lymphoma	2003	90
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Blood ImmunodeficienciesImmunologyCovid-19 EpidemiologyDeath RateCovid-19	2022	86
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913 Sabina Chiaretti, Monica Messina, Irene Della Starza, Haematologica Poor OutcomeMixed-phenotype Acute LeukemiaImmunologyPathologyEarly Recognition	2020	78

Page 1